Marianna Sabatino

Marianna Sabatino serves as Vice President and Head of Process Development at Neogene Therapeutics since April 2021, also holding the role of Site Head at the TCR Selection Facility. Prior to this, Marianna was the Head of Process Development at Autolus Ltd. from March 2020 to March 2021. Experience includes serving as Vice President of Cell Product Sciences at Arcellx and Senior Director of Early Process Development at Kite Pharma. Marianna's career commenced at the National Institutes of Health, where roles included Director of R&D Cell Processing and postdoctoral fellow. Educational credentials include a Doctor of Medicine (M.D.) from the University of Siena, completed in 2000, with a focus in Medical Oncology.